MDMA Will Focus On FDA Performance, Device Tax Repeal In 2013
This article was originally published in The Gray Sheet
The Medical Device Manufacturers Association discusses its top priorities for the new year.
You may also be interested in...
"Pura Vida" – a Spanish phrase meaning the "pure" or "simple life" – isn't just the unofficial motto of Costa Rica; rather, it's a state of mind, locals say. But as more and more medical device manufacturing facilities pop up in the tiny Central American nation, quality assurance professionals there have discovered that ensuring top-notch product quality doesn't necessarily make life simpler. To jump that hurdle, QA experts from a variety of firms – including Medtronic, Precision Concepts and Creganna Medical – have banded together to lean on each other as they search for solutions to quality systems issues, as well as knowledgeable input on hot quality and compliance topics.
The medical device excise tax was a topic of debate at a House subcommittee hearing last week, with a push by one witness to counter some arguments against the tax made by industry groups
Some device firms are trying to pass the 2.3 percent medical device excise tax onto hospitals in the form of price increases; hospitals and group purchasing organizations argue this subverts the intent of the tax provision.